BioCentury
ARTICLE | Company News

University of South Florida, Agilis Biotherapeutics deal

June 15, 2015 7:00 AM UTC

The university granted Agilis exclusive, worldwide rights to develop and commercialize UBE3a gene therapies to treat Angelman syndrome. The university will receive an undisclosed upfront payment, plus...